Researchers

  • Asunción Ávila

    Vascular risk

    Phd
  • Luis Miguel Ceresuela

    Vascular risk

  • Manuel Jesús Gómez-choco

    Vascular risk

    Phd
  • Montserrat Martín-baranera

    Vascular risk

    Phd
  • Pedro Armario

    Vascular risk

    Phd
  • Peter Blanch

    Vascular risk

    Phd
  • Rachel Hernandez

    Vascular risk

    Phd

Contact the group

Form
  • Freixa-Pamias R, Blanch Gràcia P, Rodríguez Latre ML, Basile L, Sánchez Chamero P, Gómez-Choco M, Armario P, Martínez-Rubio A, Lupón J; Working Group for coordination between Cardiology & Primary Care, Barcelona, ​​Spain. 251/20

    Impact of prescription patterns of antithrombotic treatment on atrial fibrillation-related ischemic stroke

    Curr Med Res Opin. 2020 Dec Mar;37(3):357-365
  • Gómez-Choco M, Mariaca AF, Gaebel C, Valdueza JM. 99/19

    A controlled Valsalva Maneuver causes neither Diffusion-Positive Hippocampal Lesions nor Clinical Symptoms after Transient Global Amnesia

    Eur Neurol. 2019 Dec 17:1-3. doi: 10.1159/000505185
  • Purroy F, Vena A, Forné C, de Arce AM, Dávalos A, Fuentes B, Arenillas JF, Krupinski J, Gómez-Choco M, Palomeras E, Martí-Fábregas J, Castillo J, Ustrell X, Tejada J, Masjuan J, Garcés M, Benabdelhak I, Serena J. 102/19

    Age- and Sex-Specific Risk Profiles and In-Hospital Mortality in 13,932 Spanish Stroke Patients

    Cerebrovasc Dis. 2019;47(3-4):151-164
  • Martí-Fàbregas J, Medrano-Martorell S, Merino E, Prats-Sánchez L, Marín R, Delgado-Mederos R, Martínez-Domeño A, Camps-Renom P, Jiménez-Xarrié E, Zedde M, Gómez-Choco M, Lara L, Boix A, Calleja A, De Arce-Borda AM, Bravo Y, Fuentes B, Hernández-Pérez M, Cánovas D, Llull L2, Zandio B, Freijo M, Casado-Naranjo I, Sanahuja J, Cocho D, Krupinski J , Rodríguez-Campello A, Palomeras E, De Felipe A, Serrano M, Zapata-Arriaza E, Zaragoza-Brunet J, Díaz-Maroto I, Fernández-Domínguez J, Lago A, Maestre J, Rodríguez-Yáñez M, Gich I; HERO study researchers. 103/19

    MRI predicts intracranial hemorrhage in patients who receive long-term oral anticoagulation

    Neurology. 2019;92(21):e2432-e2443
  • De la Sierra A, Armario P, Oliveras A, Banegas JR, Gorostidi M, Vinyoles E, de la Cruz JJ, Segura J, Ruilope LM. 4/18

    Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension

    J Hypertens. 2018;36(7):1563-1570
  • De la Sierra A, Pareja J, Yun S, Acosta E, Aiello F, Oliveras A, Vázquez S, Armario P, Blanch P, Sierra C, Calero F, Fernández-Llama P. 5/18

    Central blood pressure variability is increased in hypertensive patients with target organ damage

    J Clin Hypertens (Greenwich). 2018;20(2):266-272
  • Oliveras A, Armario P, Sans L, Clarà A, Vázquez S, Molina L, Pareja J, de la Sierra A, Pascual J. 6/18

    Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) study

    J Clin Hypertens (Greenwich). 2018;20(1):69-75
  • Gómez-Choco M, García-Sánchez SM, Font MA, Mengual JJ, Blanch P, Castellanos P, Cortés-Fernández MS, Martín-Castillejos C, Lleixa M, Martín-Baranera M, Armario P. 208/20

    Biomarkers levels and brachial and central blood pressure during the subacute phase of lacunar stroke and other ischemic stroke subtypes

    J Hum Hypertens. 2020 May;34(5):404-410
  • Fernández-Llama P, Pareja J, Yun S, Vázquez S, Oliveras A, Armario P, Blanch P, Calero F, Sierra C, de la Sierra A. 1411

    Cuff-Based Oscillometric Central and Brachial Blood Pressures Obtained Through ABPM are Similarly Associated with Renal Organ Damage in Arterial Hypertension.

    Kidney Blood Pressure Res. 2017;42(6):1068-1077.
  • Armario P, Calhoun DA, Oliveras A, Blanch P, Vinyoles E, Banegas JR, Gorostidi M, Segura J, Ruilope LM, Dudenbostel T, de la Sierra A. 1396

    Prevalence and Clinical Characteristics of Refractory Hypertension

    J Am Heart Assoc. 2017:6(12).

Projects

  • Vascular risk

    Researcher
    • Year 2020
    • HSDMB

    Randomised, double-blind, placebo-controlled, clinical study to evaluate the effect of opicapone 50 mg on Parkinson's disease patients with motor fluctuations and associated pain.

    • DISTRICT ATTORNEY:

      Bial - Portela & Ca, SA

    • TYPE E:

      RD2015

  • Vascular risk

    Researcher
    • Year 2020
    • HSDMB

    Frequency and clinical and prognostic implications of the presence of ARIA in patients with cerebral amyloid angiopathy.

    • DISTRICT ATTORNEY:

      Dr. Manuel Gomez

    • TYPE E:

      PI

  • Vascular risk

    Researcher
    • Year 2020
    • HSDMB

    Progression of large vessel vascular involvement in patients with ischemic stroke associated with giant cell arteritis. The role of vascular imaging.

    • DISTRICT ATTORNEY:

      Dr. Manuel Gomez

    • TYPE E:

      PI

  • Vascular risk

    Researcher
    • Year 2020
    • HSDMB

    Is the infection by COVID-19 a prognostic factor for the patient with acute ischemic stroke? COVICTUS study.

    • DISTRICT ATTORNEY:

      Research Institute of the Hospital de la Santa Creu i Sant Pau – IIB Sant Pau

    • TYPE E:

      PI

  • Vascular risk

    Researcher
    • Year 2020
    • HSDMB

    Study of factors influencing thrombolytic treatment in patients with minor stroke.

    • DISTRICT ATTORNEY:

      Dr. Manuel Gómez Choco

    • TYPE E:

      PI

  • Vascular risk

    Researcher
    • Year 2020
    • HSDMB

    Remote ischemic conditioning in patients with acute ischemic stroke in Catalonia (REMOTE-CAT).

    • DISTRICT ATTORNEY:

      Dr. Francesc Purroy García - Foundation Dr. Pifarré–Institute for Biomedical Research of Lleida (IRBLleida)

    • TYPE E:

      PS

    • Year 2020
    • HSDMB

    Randomised, double-blind, placebo-controlled, clinical study to evaluate the effect of opicapone 50 mg on Parkinson's disease patients with motor fluctuations and associated pain.

    • DISTRICT ATTORNEY:

      Bial - Portela & Ca, SA

    • TYPE E:

      RD2015

    • Year 2020
    • HSDMB

    Frequency and clinical and prognostic implications of the presence of ARIA in patients with cerebral amyloid angiopathy.

    • DISTRICT ATTORNEY:

      Dr. Manuel Gomez

    • TYPE E:

      PINE TREE

    • Year 2020
    • HSDMB

    Progression of large vessel vascular involvement in patients with ischemic stroke associated with giant cell arteritis. The role of vascular imaging.

    • DISTRICT ATTORNEY:

      Dr. Manuel Gomez

    • TYPE E:

      PINE TREE

    • Year 2020
    • HSDMB

    Is infection by COVID-19 a prognostic factor for patients with acute ischemic stroke? COVICTUS study.

    • DISTRICT ATTORNEY:

      Research Institute of the Hospital de la Santa Creu i Sant Pau – IIB Sant Pau

    • TYPE E:

      PINE TREE

Lines of action

  • Resistant hypertension and refractory hypertension
  • Arterial stiffness in hypertension and cerebrovascular disease
  • Small vessel cerebrovascular disease: Lacunar infarction
  • Factors associated with stroke recurrences
  • Thrombolytic treatment and acute stroke care circuits
  • Prognostic value of premorbid BP and BP in the acute phase of stroke

Documents

Information of interest

Links